99% Savings - Buy Just @1 Rs X
Telmikind Beta 50 Mg Tablet is a prescription medicine that is available as a Tablet. The alternative uses of Telmikind Beta 50 Mg Tablet have also been explained below.
The correct dosage of Telmikind Beta 50 Mg Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Telmikind Beta 50 Mg Tablet include Headache, Dizziness, Weakness. Besides the aforementioned side effects, there are other adverse effects of Telmikind Beta 50 Mg Tablet as well, which are listed below. Normally, these side effects of Telmikind Beta 50 Mg Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Telmikind Beta 50 Mg Tablet's effect is Severe during pregnancy and Safe for lactating mothers. In addition, Telmikind Beta 50 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Telmikind Beta 50 Mg Tablet related warnings section.
Individuals suffering from medical conditions like Diabetes, Congestive Heart Failure (CHF), Angioedema must refrain from the use of Telmikind Beta 50 Mg Tablet since this can cause severe adverse effects.
Drug interactions for Telmikind Beta 50 Mg Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Telmikind Beta 50 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Telmikind Beta 50 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Telmikind Beta 50 Mg Tablet safe for pregnant women?
Telmikind Beta can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Telmikind Beta 50 Mg Tablet safe during breastfeeding?
Telmikind Beta is completely safe for breastfeeding women.
What is the effect of Telmikind Beta 50 Mg Tablet on the Kidneys?
Kidney can be affected by Telmikind Beta. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Telmikind Beta 50 Mg Tablet on the Liver?
Telmikind Beta can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Telmikind Beta 50 Mg Tablet on the Heart?
Side effects of Telmikind Beta rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Telmikind Beta 50 Mg Tablet unless your doctor advises you to do so -
Is this Telmikind Beta 50 Mg Tablet habit forming or addictive?
No, you will not get addicted to Telmikind Beta 50 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking Telmikind Beta 50 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Telmikind Beta 50 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Telmikind Beta 50 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Telmikind Beta 50 Mg Tablet
There is no information on the effects of taking Telmikind Beta 50 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Telmikind Beta 50 Mg Tablet
Information about the interaction of Telmikind Beta 50 Mg Tablet and alcohol is not currently available because this topic has not been researched yet.
Yes, Telmikind Beta causes hyperkalemia (high amount of potassium in the blood). Therefore, monitoring of blood potassium levels is important during Telmikind Beta therapy.
No, Telmikind Beta is not a beta blocker/calcium channel blocker/diuretic/blood thinner/ace inhibitor. It is angiotensin II receptor blocker (an antihypertensive drug).
Yes, Telmikind Beta may cause a cough on rare occasions. If you experience a cough while taking Telmikind Beta, please talk to your doctor immediately.
Telmikind Beta is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Telmikind Beta might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Telmikind Beta exactly as prescribed by their doctor.
Yes, Telmikind Beta causes hyponatremia (low level of sodium in the blood). Treatment with telmisartan might call for a regular blood monitoring for checking sodium levels.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850